Decentralized Clinical Trials (DCTs)

about us module image_desktop about us module image_desktop

ProPharma offers Decentralized Clinical Trial (DCT) services in both a hybrid and fully virtual model to ensure whatever your needs are, we are able to accommodate them. If you need assistance with your trials, or help determining if a DCT model works for your project, reach out to our experts today for a consultation.

What Are Decentralized Clinical Trials?

Decentralized Clinical Trials (DCTs) are studies that are supported by local or mobile healthcare providers that focus on bringing activities to patients instead of bringing patients to trial sites. As a result, Decentralized Clinical Trials reduce patient burden while increasing patient recruitment, retention, and inclusion. The increased flexibility of DCTs expands the geographical reach, and enhances the patient experience while providing Sponsors with reliable data. Trial decentralization provides the opportunity for study visits to take place in a location convenient to the patient, supported by our team of GoClinical Clinicians who are trained in GCP and protocol-specific procedures. In fact, some patients may be eligible to receive in-home clinical trial services.

Statistics About Clinical Trials

  • 70% of patients live more than two hours from a research site
  • 87% of Sponsors plan to utilize DCT in 2022; only 28% planned to use DCT before the pandemic
  • 85% of trials fail to retain enough patients

Benefits of Implementing a Decentralized Clinical Trial

  • Improved patient recruitment and retention
  • Expanded geographical reach
  • Increased patient diversity
  • Increased flexibility and convenience for patients, providing a differentiator for the Sponsor over competing studies
  • Sites can enroll and complete high complexity visits while GoClinical Clinicians attend to frequent and routine visits in the field
  • Ensured continuity of care if sites are unable to cover visits due to COVID-19 or other unforeseen issues

Typical Assessments for Decentralized Visits

Our decentralized visits include critical procedures for your clinical trial’s success. Let our team of experts review your protocol or draft synopsis and consult with your team on what visits or studies could benefit from a DCT model. Our procedural capabilities are as follows:

Vital Signs and Associated Variables

  • Temperature
  • Respirations
  • Blood Pressure
  • Pulse/Pulse Oximetry
  • Weight/Height/BMI

Lab Sample Collection and Processing

  • Blood/Plasma
  • Urine
  • Saliva/Sputum
  • Stool
  • Finger Sticks

IP Logistics

Per Protocol Assessments

Targeted Nursing Assessments

IP Administration

  • Infusion
  • Injection
  • Oral
  • Topical

Telehealth Support

Patient Reported Outcomes/Scales

Patient Training

  • IP Administration
  • Diary Completion
  • Device

Other Safety Assessments

  • Changes in Health Status
  • Concomitant and Treatment Medications
  • ECG

Why Decentralize Your Trial?

Once viewed as nice-to-have pilot projects, DCTs have quickly become a strategic priority – benefiting both the participants and the sponsors. Outsourcing DCT has become even more common with the pandemic, offering the continuation of clinical studies despite limited capabilities.

ProPharma recognizes that patients are not just statistics or data – they’re people. For many potential clinical trial participants, managing a health condition is only one aspect of their life. Requiring these patients and their families or caregivers to attend site visits, which typically involves hours of travel time and additional costs, is a lot to ask, and for some, can be impossible.

From eliminating transportation, site set-up cost, and hassle to capturing real-time data, there are countless reasons to consider a decentralized clinical trial. For participants, geographical barriers are eliminated giving you a larger, more diverse pool of eligible patients to sample from – providing a more efficient recruitment process. Additionally, patient safety and comfort are increased, while an in-person clinical relationship is built, increasing patient trust and retention.

Which DCT Model is Right for Your Study?

  • Hybrid Clinical Trials – sites are still involved in this model and patients have the option of having certain agreed-upon visits performed at a convenient, alternate location such as their home, office, school, etc. Hybrid models work well with outsourcing, as companies can choose specific aspects of their clinical trial in which to outsource.
  • Virtual Clinical Trials – patients are never required to go to a site for study visits, all visits take place at an alternate location. ProPharma is one of a handful of companies that offer virtual decentralized clinical trials.

Most Sponsors are adopting a Hybrid Clinical Trial model, but our team is able to support both Hybrid and Virtual clinical trials.

Not sure where to start? Our team of experts has 10 plus years of experience in the DCT space and can help guide your company on what studies make sense for DCT or what challenges we would need to work through to implement a DCT model. Contact us to help determine which models work the best for your study.

Why Choose ProPharma’s Decentralized Clinical Trials?

Nursing

ProPharma has 300 full-time GoClinical Clinicians (RNs, LNs, and Phlebotomists) on staff to support your patients. Furthermore, we have an expansive network of more than 25,000 nursing professionals through our sister companies. This scope ensures that whatever your DCT needs are, ProPharma has the scale and capability to ensure your trial runs smoothly.

Technology

GoClinical, our proprietary 21 CFR Part 11 compliant technology platform, allows the collection of source data from decentralized visits and electronically sends it for entry into the EDC. This approach to source collection significantly reduces source turnaround times, reduces documentation errors, and improves PI oversight.

Experience and Global Reach

ProPharma has 27 offices worldwide spanning six continents, providing a truly global footprint to support your decentralized clinical trials. ProPharma has 20 years of experience supporting sponsors from early development through commercialization allows for expert insight at any phase or function of your study and a streamlined approach from a single provider. Our DCT leadership team has over ten years of experience in the DCT space to help your team design and implement the right DCT solutions. Whether you’re interested in hybrid or virtual clinical trials, our team of experts can help.

Therapeutic Expertise

Our team has vast experience managing studies across all therapeutic areas and phases for clinical and device trials. Among the most common:

  • Anti-infectives
  • Neuroscience / Neurology
  • Cardiovascular
  • Onco-immunology
  • Central Nervous System
  • Oncology
  • Dermatology
  • Ophthalmology
  • Device and Diagnostics
  • Pulmonary / Respiratory
  • Endocrine / Metabolic
  • Rare and Orphan Diseases
  • Gastrointestinal
  • Rheumatology
  • Immunology

Need Help Incorporating DCT into Your Clinical Trials?

We have more than 10 years of experience helping sponsors implement decentralized visits for their clinical trials.

News & Insights

General Regulatory FDA Meetings Regulatory Sciences Formal FDA Meetings for Sponsors or Applications of PDUDA Products

February 23, 2024

Formal FDA Meetings for Sponsors or Applications of PDUDA Products

This article has been updated since its original February 28, 2017 publication. Since the introduction of the Prescription Drug User Fee Act (PDUFA) VII for fiscal years 2023 - 2027, the FDA...

Meet the Expert Medical Information Meet the Expert: Eric Brandon

February 22, 2024

Meet the Expert: Eric Brandon

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and...

Quality & Compliance FDA CAPA Quality Assurance Life Science Consulting Demystifying CAPA Management: Overcoming Challenges in the Fast-Paced World of GMP

February 19, 2024

Demystifying CAPA Management: Overcoming Challenges in the Fast-Paced World of GMP

This article has been updated since its original publication date. Navigating the complexities of Corrective Action / Preventive Action (CAPA) in the drug and medical device industries often poses a...

Press Releases ProPharma Announces the Appointment of Vicki Gashwiler as Vice President of Clinical Operations, Medical Technology

January 24, 2024

ProPharma Announces the Appointment of Vicki Gashwiler as Vice President of Clinical Operations, Medical Technology

RALEIGH, January 24, 2024, ProPharma Group (ProPharma), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey...

Company News Press Releases Innovation and the Black Swan Prodigy Whitepaper

January 4, 2024

Innovation and the Black Swan Prodigy Whitepaper

Check out our comprehensive whitepaper, "Innovation and the Black Swan: the Imperative of AI-enabled clinical research," for an in-depth look at how embracing AI-enabled tools and technologies is...

Press Releases ProPharma Unveils Prodigy: Groundbreaking Technology-Enabled Consulting Platform to Revolutionize Life Science Consulting Industry

January 4, 2024

ProPharma Unveils Prodigy: Groundbreaking Technology-Enabled Consulting Platform to Revolutionize Life Science Consulting Industry

Whitepaper published alongside today's announcement details $5M+ investment and up to 50% improvement in speed, quality, and cost with new AI-enhanced solutions. RALEIGH, NC, January 4, 2023 –...

Press Releases Awards EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Entrepreneur Of The Year® celebrates ambitious entrepreneurs who are building a better world. RALEIGH, NC, November 27, 2023 – Ernst & Young LLP (EY US) today announced that Chief Executive Officer,...

Press Releases Awards ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

October 11, 2023

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

Raleigh, NC, October 11, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...

Press Releases Awards ProPharma Recognized by Inc. 5000 List of America’s Fastest-Growing Companies

August 15, 2023

ProPharma Recognized by Inc. 5000 List of America’s Fastest-Growing Companies

ProPharma Recognized on the Inc. 5000 List of America’s Fastest-Growing Companies After a year of Growth and Innovation, ProPharma achieved its highest rank in 20+ year history. RALEIGH, NC, August...

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

Press Releases ProPharma Announces the Appointment of Vicki Gashwiler as Vice President of Clinical Operations, Medical Technology

January 24, 2024

ProPharma Announces the Appointment of Vicki Gashwiler as Vice President of Clinical Operations, Medical Technology

RALEIGH, January 24, 2024, ProPharma Group (ProPharma), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey...

Company News Press Releases Innovation and the Black Swan Prodigy Whitepaper

January 4, 2024

Innovation and the Black Swan Prodigy Whitepaper

Check out our comprehensive whitepaper, "Innovation and the Black Swan: the Imperative of AI-enabled clinical research," for an in-depth look at how embracing AI-enabled tools and technologies is...

Press Releases ProPharma Unveils Prodigy: Groundbreaking Technology-Enabled Consulting Platform to Revolutionize Life Science Consulting Industry

January 4, 2024

ProPharma Unveils Prodigy: Groundbreaking Technology-Enabled Consulting Platform to Revolutionize Life Science Consulting Industry

Whitepaper published alongside today's announcement details $5M+ investment and up to 50% improvement in speed, quality, and cost with new AI-enhanced solutions. RALEIGH, NC, January 4, 2023 –...

Previous Post Arrow Next Post Arrow
%}
Press Releases Awards EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Entrepreneur Of The Year® celebrates ambitious entrepreneurs who are building a better world. RALEIGH, NC, November 27, 2023 – Ernst & Young LLP (EY US) today announced that Chief Executive Officer,...

Press Releases Awards ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

October 11, 2023

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

Raleigh, NC, October 11, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...

Press Releases Awards ProPharma Recognized by Inc. 5000 List of America’s Fastest-Growing Companies

August 15, 2023

ProPharma Recognized by Inc. 5000 List of America’s Fastest-Growing Companies

ProPharma Recognized on the Inc. 5000 List of America’s Fastest-Growing Companies After a year of Growth and Innovation, ProPharma achieved its highest rank in 20+ year history. RALEIGH, NC, August...

Previous Award Arrow Next Award Arrow
General Regulatory FDA Meetings Regulatory Sciences Formal FDA Meetings for Sponsors or Applications of PDUDA Products

February 23, 2024

Formal FDA Meetings for Sponsors or Applications of PDUDA Products

This article has been updated since its original February 28, 2017 publication. Since the introduction of the Prescription Drug User Fee Act (PDUFA) VII for fiscal years 2023 - 2027, the FDA...

Meet the Expert Medical Information Meet the Expert: Eric Brandon

February 22, 2024

Meet the Expert: Eric Brandon

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and...

Quality & Compliance FDA CAPA Quality Assurance Life Science Consulting Demystifying CAPA Management: Overcoming Challenges in the Fast-Paced World of GMP

February 19, 2024

Demystifying CAPA Management: Overcoming Challenges in the Fast-Paced World of GMP

This article has been updated since its original publication date. Navigating the complexities of Corrective Action / Preventive Action (CAPA) in the drug and medical device industries often poses a...

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow